BDBM3302 4-Anilinoquinazoline deriv. 53::4-[(3-bromophenyl)amino]quinazoline-6,7-diol::44 (3-Bromophenyl)amino]-6,7-dihydroxyquinazoline::CHEMBL93032

SMILES Oc1cc2ncnc(Nc3cccc(Br)c3)c2cc1O

InChI Key InChIKey=CZMCXMIIVHUIPE-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 3302   

TargetEpidermal growth factor receptor(Human)
Parke-Davis Pharmaceutical Research

LigandPNGBDBM3302(4-[(3-bromophenyl)amino]quinazoline-6,7-diol | 44 ...)
Affinity DataIC50: 0.170nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2005
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Parke-Davis Pharmaceutical Research

LigandPNGBDBM3302(4-[(3-bromophenyl)amino]quinazoline-6,7-diol | 44 ...)
Affinity DataIC50: 0.170nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2005
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Parke-Davis Pharmaceutical Research

LigandPNGBDBM3302(4-[(3-bromophenyl)amino]quinazoline-6,7-diol | 44 ...)
Affinity DataIC50: 0.174nMAssay Description:Inhibition of EGFRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed